查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1478024

熱原測試市場：依產品類型、最終用戶、地區 - 全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031 年

Pyrogen Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 444 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究最近發佈了對全球熱原測試市場的深入分析，全面概述了關鍵市場動態、成長動力/課題和新興趨勢。該報告提供了預測 2024 年至 2031 年市場成長軌蹟的獨家數據和統計數據，並提供了有關熱原測試市場的寶貴見解。

全球熱原測試市場預計到2024年將達到20.4億美元，並在未來10年以12.2%的複合年增長率成長。預測表明，到2031年，市場收入將飆升至45.6億美元，表明市場將出現顯著且積極的擴張。

重要見解

  • 熱原測試市場規模（2024 年）：20.4 億美元
  • 市場預測金額（2031年）：45.6億美元
  • 全球市場成長率（2024-2031）：複合年增長率12.2%

熱原測試市場 - 報告範圍：

熱原測試是製藥和醫療器材製造的重要方面，透過檢測熱原污染來確保產品的安全性和有效性。本報告探討了推動熱原測試在全球範圍內採用的各種應用和技術進步。

有幾個因素正在推動熱原測試市場的成長。嚴格的監管要求、對病人安全的日益關注以及熱原污染事件的增加正在推動市場擴張。此外，測試技術的進步，例如體外方法和自動化系統的採用，正在提高測試的準確性和效率，進一步刺激市場成長。

市場成長動力：

熱原測試市場受益於要求熱原污染測試的製藥和醫療器材製造的嚴格監管環境。此外，製造商越來越認識到熱原測試對於確保產品安全和合規性的重要性，這正在推動市場需求。此外，測試方法的技術進步（例如快速自動化測試系統的引入）正在透過簡化測試流程和縮短交付時間來推動市場成長。

市場限制因素：

儘管預計會出現成長，但熱原測試市場也存在課題。與測試程序和設備相關的高成本是中小企業進入市場的障礙。此外，測試方法的複雜性和對專業知識的需求限制了採用率，特別是在新興國家。此外，對某些測試方法的準確性和可靠性的擔憂可能會阻礙市場成長，因此需要繼續進行研究和開發來應對這些課題。

市場機會：

熱原測試市場存在巨大的創新和擴展機會。旨在改善檢測方法、提高靈敏度和特異性、降低檢測成本的持續研發是打開新市場的關鍵。此外，將機器人和人工智慧等先進技術整合到檢測系統中可以進一步簡化流程並提高效率，從而推動市場成長。

本報告解決的關鍵問題

  • 推動熱原測試市場成長的關鍵因素是什麼？
  • 哪些產業和應用程式正在推動熱原測試的需求？
  • 技術進步如何改變熱原測試市場的競爭格局？
  • 誰是全球熱原測試市場的主要參與者？
  • 全球熱原測試市場的新興趨勢和未來前景預測是什麼？

競爭資訊與經營策略：

在熱原測試設備領域，製造商策略性地將重點放在監管批准、產品發佈和收購上，以提高其在市場上的影響力。一項值得注意的進展是，Eurofins 於 2022 年 1 月推出了 PFAS Exposure(TM)，這是第一個測量 PFAS 水平的家庭測試。同樣，2021 年 4 月，Associates of Cape Cod, Inc. (ACC) 推出了 PyroSmart NextGen□，這是一種用於細菌內毒素檢測 (BET) 的創新重組鱟試劑。Lonza 於 2020 年 10 月推出的 Pyrocell 單核細胞活化測試系統提供了全面的體外熱原測試解決方案，將 Sankin 的優化 MAT 試劑與 Lonza 的介質和配件相結合。持久性市場研究正在密切追蹤熱原測試領域的此類市場發展，並在綜合報告中提供詳細的見解。

主要公司簡介

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • MAT-BioTech
  • Promega Corporation
  • GenScript
  • Associates of Cape Cod, Inc.
  • BIOMERIEUX SA
  • Ella A/S
  • Hycult Biotech Inc.
  • Eurofins Biolab Srl
  • Solvias AG
  • Wickham Laboratories Ltd.
  • Sotera Health (Nelson Laboratories, LLC)
  • Charles River Laboratories
  • Creative Biolabs
  • Sanquin Reagents B.V.
  • Fujifilm Wako Pure Chemical Corporation
  • MAT Research
  • Xiamen Bioendo Technology Co. Ltd.
  • Microcoat Biotechnologie GmbH
  • PerkinElmer Inc.
  • Orchid Scientific & Innovative Pvt Ltd.

熱原測試市場細分

熱原測試市場：依產品/服務分類

  • 機器

數位溫度計設備

全自動內毒素檢測裝置

便攜式內毒素檢測設備

□標儀

  • 測試套件/試劑

重組因子C測定方法

鱟變形細胞裂解物 (LAL) 測試

  • 試色
  • 濁度測量
  • 凝膠凝塊試驗

兔熱原試驗

單核細胞活性測定方法

  • 消耗品
  • 服務

內毒素檢測服務

單核細胞活化測試服務

依來源劃分的熱原測試市場

  • 基於體外的熱原測試

全血單核細胞

基於週邊血單核細胞 (PBMC) 的單核細胞

基於細胞系的單核細胞

  • 動物熱原測試

重組因子 (rFC)

細菌內毒素（BET）

兔熱原試驗

依應用劃分的熱原測試市場

  • 注射療法
  • 疫苗接種
  • 口服藥物
  • 生物製劑
  • 植入式醫療器械
  • 透析液
  • 有毒/免疫調節藥物
  • 血液製品

熱原測試市場：依最終用戶分類

  • 製藥公司
  • 生物技術公司
  • 醫療器材公司
  • 診斷實驗室
  • 臨床研究組織（CRO）
  • 臨床製造組織 (CMO)

熱原測試市場：依地區

  • 北美熱原測試市場
  • 拉丁美洲熱原測試市場
  • 歐洲熱原測試市場
  • 南亞熱原測試市場
  • 東亞熱原測試市場
  • 大洋洲熱原測試市場
  • 中東和非洲熱原測試市場

目錄

第一章內容提要

第二章市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含/排除

第 3 章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章關鍵成功因素

  • 臨床試驗分析
  • 未滿足的需求
  • 監管場景
  • 熱原和內毒素的檢測方法
  • 預計進行的測試數量

第五章市場背景

  • 宏觀經濟因素
  • 預測變量 - 相關性和影響
  • 市場動態

第 6 章 COVID19 危機分析

  • 目前的 COVID-19 統計數據和未來潛在的影響
  • 目前經濟預測 與 2008 年相比的經濟分析
  • COVID-19 對醫療保健產業的影響
  • COVID-19 對全球熱原測試市場的影響

第七章全球熱原測試市場需求及數量分析

  • 2019-2023 年歷史市場量分析
  • 2024-2031 年當前和未來市場量預測
    • 同比增長趨勢分析

第八章全球熱原測試市場-價格分析

  • 全球平均價格分析基準
  • 價格分析：依地區
  • 定價假設

第九章全球熱原測試市場需求分析

  • 2019-2023年歷史市值分析
  • 當前和未來市場價值預測，2024-2031
    • 同比增長趨勢分析
    • 絕對量機會分析

第10章全球熱原測試市場分析：依產品和服務

  • 簡介/主要發現
  • 過去的市場規模和數量分析：依產品/服務，2019-2023
  • 目前和未來的市場規模和數量分析與預測：依產品和服務劃分，2024-2031 年
    • 機器
    • 測試套件/試劑
    • 消耗品
    • 服務
  • 市場吸引力分析：依產品/服務

第十一章全球熱原測試市場分析：依來源分類

  • 簡介/主要發現
  • 過去的市場規模分析（依來源地），2019-2023
  • 當前和未來的市場規模分析和預測：依來源劃分，2024-2031 年
    • 基於體外
    • 基於動物
  • 市場吸引力分析：依來源劃分

第十二章全球熱原測試市場分析：依應用分類

  • 簡介/主要發現
  • 歷史市場規模分析：依應用分類，2019-2023
  • 目前和未來市場規模的分析和預測：依應用分類，2024-2031
    • 注射
    • 疫苗接種
    • 口服藥物
    • 生物製品
    • 植入式醫療器械
    • 透析液
    • 有毒/免疫調節藥物
    • 血液衍生產品
  • 市場吸引力分析：依應用

第 13 章全球熱原測試市場分析：依最終用戶分類

  • 簡介/主要發現
  • 歷史市場規模分析：依最終用戶劃分，2019-2023
  • 當前和未來市場規模的分析和預測：依最終用戶劃分，2024-2031 年
    • 製藥公司
    • 生物技術公司
    • 醫療器材公司
    • 診斷實驗室
    • 臨床研究組織（CRO）
    • 臨床製造組織 (CMO)
  • 市場吸引力分析：依最終用戶

第14章全球熱原測試市場分析：依地區

  • 介紹
  • 歷史市場規模與數量分析：依地區劃分，2019-2023
  • 當前市場規模和數量分析及預測：依地區劃分，2024-2031 年
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲 (MEA)
  • 市場吸引力分析：依地區

第十五章北美熱原測試市場分析

第十六章拉丁美洲熱原測試市場分析

第十七章歐洲熱原測試市場分析

第十八章南亞熱原測試市場分析

第十九章東亞熱原測試市場分析

第二十章 大洋洲熱原測試市場分析

第21章中東和非洲熱原測試市場分析

第 22 章 2024-2031 年各國熱原測試市場分析

  • 介紹
  • 美國熱原測試市場分析
  • 加拿大熱原測試市場分析
  • 墨西哥熱原測試市場分析
  • 巴西熱原測試市場分析
  • 德國熱原測試市場分析
  • 義大利熱原測試市場分析
  • 法國熱原測試市場分析
  • 英國熱原測試市場分析
  • 西班牙熱原測試市場分析
  • 俄羅斯熱原測試市場分析
  • 比荷盧熱原測試市場分析
  • 中國熱原檢測市場分析
  • 日本熱原測試市場分析
  • 韓國熱原測試市場分析
  • 印度熱原測試市場分析
  • 泰國熱原檢測市場分析
  • 澳洲熱原測試市場分析
  • 紐西蘭熱原檢測市場分析
  • GCC國家熱原測試市場分析
  • 土耳其熱原測試市場分析
  • 南非熱原測試市場分析
  • 印尼熱原測試市場分析
  • 馬來西亞熱原測試市場分析

第23章市場結構分析

  • 市場分析：依公司層級
  • 主要參與者的市場佔有率分析
  • 市場存在分析

第 24 章 競爭分析

  • 比賽儀表板
  • 競爭標桿
  • 競爭對手詳情
    • Thermo Fisher Scientific
    • Merck KGaA
    • Lonza
    • MAT-BioTech
    • Promega Corporation
    • GenScript
    • Associates of Cape Cod, Inc.
    • BIOMERIEUX SA
    • Ella A/S
    • Hycult Biotech Inc.
    • Eurofins Biolab Srl
    • Solvias AG
    • Wickham Laboratories Ltd.
    • Sotera Health（Nelson Laboratories, LLC）
    • Charles River Laboratories
    • Creative Biolabs
    • Sanquin Reagents BV
    • Fujifilm Wako Pure Chemical Corporation
    • MAT Research
    • Xiamen Bioendo Technology Co. Ltd.
    • Microcoat Biotechnologie GmbH
    • PerkinElmer Inc.
    • Orchid Scientific &Innovative Pvt Ltd.

第 25 章先決條件和使用的縮寫詞

第26章研究方法論

簡介目錄
Product Code: PMRREP4259

Persistence Market Research has recently published an in-depth analysis of the global Pyrogen Testing Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the Pyrogen Testing Market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2024 to 2031.

The global pyrogen testing market reached US$ 2.04 billion in 2024 and is expected to grow at a CAGR of 12.2% over the next decade. Projections suggest that market revenue will soar to US$ 4.56 billion by 2031, indicating significant and positive market expansion.

Key Insights:

  • Pyrogen Testing Market Size (2024) - US$ 2.04 Bn
  • Projected Market Value (2031) - US$ 4.56 Bn
  • Global Market Growth Rate (2024-2031) - 12.2% CAGR

Pyrogen Testing Market - Report Scope:

Pyrogen testing serves as a critical aspect of pharmaceutical and medical device manufacturing, ensuring the safety and efficacy of products by detecting pyrogen contamination. This report explores the diverse applications and technological advancements driving the adoption of pyrogen testing globally.

Several factors drive the growth of the pyrogen testing market. Stringent regulatory requirements, increasing focus on patient safety, and rising incidences of pyrogen contamination incidents propel market expansion. Additionally, advancements in testing methodologies, such as the adoption of in vitro methods and automated systems, enhance testing accuracy and efficiency, further stimulating market growth.

Market Growth Drivers:

The pyrogen testing market benefits from the stringent regulatory landscape governing pharmaceutical and medical device manufacturing, which mandates the testing of products for pyrogen contamination. Additionally, increasing awareness among manufacturers regarding the importance of pyrogen testing in ensuring product safety and compliance drives market demand. Moreover, technological advancements in testing methodologies, such as the introduction of rapid and automated testing systems, streamline testing processes and reduce turnaround time, fostering market growth.

Market Restraints:

Despite growth prospects, challenges exist in the pyrogen testing market. High costs associated with testing procedures and equipment pose barriers to market entry for small and medium-sized enterprises. Furthermore, the complexity of testing methodologies and the need for specialized expertise limit adoption rates, particularly in emerging economies. Moreover, concerns regarding the accuracy and reliability of certain testing methods may impede market growth, necessitating ongoing research and development efforts to address these challenges.

Market Opportunities:

The pyrogen testing market presents significant opportunities for innovation and expansion. Continued research and development aimed at improving testing methodologies, enhancing sensitivity and specificity, and reducing testing costs are key to unlocking new market avenues. Additionally, the integration of advanced technologies such as robotics and artificial intelligence into testing systems can further streamline processes and improve efficiency, driving market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Pyrogen Testing Market?
  • Which industries and applications are driving the demand for Pyrogen Testing?
  • How are technological advancements reshaping the competitive landscape of the Pyrogen Testing Market?
  • Who are the leading players in the global Pyrogen Testing Market?
  • What emerging trends and future prospects are anticipated in the global Pyrogen Testing Market?

Competitive Intelligence and Business Strategy:

In the realm of pyrogen testing devices, manufacturers are strategically focusing on regulatory approvals, product launches, and acquisitions to bolster their market presence. Eurofins' introduction of PFAS Exposure(TM) in January 2022, the first at-home test for measuring PFAS levels, is a notable advancement. Similarly, Associates of Cape Cod, Inc. (ACC) unveiled PyroSmart NextGen(TM) in April 2021, an innovative recombinant LAL reagent for Bacterial Endotoxin Testing (BET). Lonza's October 2020 launch of the Pyro Cell Monocyte Activation Test System provides a comprehensive in-vitro pyrogen testing solution, combining optimized MAT reagents from Sanquin with Lonza's media and accessories. Persistence Market Research diligently tracks such developments in the pyrogen testing sector, offering detailed insights in their comprehensive report.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • MAT-BioTech
  • Promega Corporation
  • GenScript
  • Associates of Cape Cod, Inc.
  • BIOMERIEUX SA
  • Ella A/S
  • Hycult Biotech Inc.
  • Eurofins Biolab Srl
  • Solvias AG
  • Wickham Laboratories Ltd.
  • Sotera Health (Nelson Laboratories, LLC)
  • Charles River Laboratories
  • Creative Biolabs
  • Sanquin Reagents B.V.
  • Fujifilm Wako Pure Chemical Corporation
  • MAT Research
  • Xiamen Bioendo Technology Co. Ltd.
  • Microcoat Biotechnologie GmbH
  • PerkinElmer Inc.
  • Orchid Scientific & Innovative Pvt Ltd.

Pyrogen Testing Market Segmentation

Pyrogen Testing Market by Product & Service:

  • Instruments

Digital Tele Thermometers Equipment

Automated Endotoxin Testing Equipment

Portable Endotoxin Testing Equipment

Microplate Readers

  • Test Kits & Reagents

Recombinant Factor C Assays

Limulus Amebocyte Lysate (LAL) Tests

  • Chromogenic Tests
  • Turbid metric Tests
  • Gel-Clot Tests

Rabbit Pyrogen Tests

Monocyte Activity Assays

  • Consumables
  • Services

Endotoxin Testing Services

Monocyte Activation Testing Services

Pyrogen Testing Market by Source:

  • In-vitro-based Pyrogen Testing

Whole Blood-based Monocytes

Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes

Cell Line-based Monocytes

  • Animal-based Pyrogen Testing

Recombinant Factor (rFC )

Bacterial Endotoxins (BET)

Rabbit Pyrogen Tests

Pyrogen Testing Market by Application:

  • Injectable Therapeutics
  • Vaccines
  • Orally-dosed Pharmaceuticals
  • Biologics
  • Implantable Medical Devices
  • Dialysis Liquids
  • Toxic/immune-modulatory Drugs
  • Blood-based Products

Pyrogen Testing Market by End User:

  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Diagnostic Laboratories
  • Clinical Research Organizations (CROs)
  • Clinical Manufacturing Organizations (CMOs)

Pyrogen Testing Market by Region:

  • North America Pyrogen Testing Market
  • Latin America Pyrogen Testing Market
  • Europe Pyrogen Testing Market
  • South Asia Pyrogen Testing Market
  • East Asia Pyrogen Testing Market
  • Oceania Pyrogen Testing Market
  • Middle East & Africa Pyrogen Testing Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Clinical Trial Analysis
  • 4.2. Unmet Needs
  • 4.3. Regulatory Scenario
  • 4.4. Methods of Pyrogen and Endotoxin Detection
  • 4.5. Estimated number of tests performed

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Life Science Market Outlook
    • 5.1.4. Global Pyrogen Testing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Rising incidence of chronic diseases
    • 5.2.3. Increased spending on pyrogen and endotoxin testing
    • 5.2.4. Shift towards in-vitro testing
    • 5.2.5. Adoption of alternative testing methods
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

  • 6.1. Current COVID 19 Statistics and Probable Future Impact
  • 6.2. Current Economic Projection as compared to 2008 Economic analysis
  • 6.3. Impact of COVID-19 on the healthcare industry.
  • 6.4. Impact of COVID-19 on the global Pyrogen Testing market.

7. Global Pyrogen Testing Market Demand, in Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2031

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Pyrogen Testing Market - Pricing Analysis

  • 8.1. Global Average Pricing Analysis Benchmark
  • 8.2. Price Analysis by Region.
  • 8.3. Pricing Assumptions

9. Global Pyrogen Testing Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Products & Services

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Products & Services, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Products & Services, 2024-2031
    • 10.3.1. Instruments
      • 10.3.1.1. Digital Tele Thermometers Equipment
      • 10.3.1.2. Automated Endotoxin Testing Equipment
      • 10.3.1.3. Portable Endotoxin Testing Equipment
      • 10.3.1.4. Microplate Readers
    • 10.3.2. Test Kits & Reagents
      • 10.3.2.1. Recombinant Factor C Assays
      • 10.3.2.2. Limulus Amebocyte Lysate (LAL) Tests
        • 10.3.2.2.1. Chromogenic Tests
        • 10.3.2.2.2. Turbidimetric Tests
        • 10.3.2.2.3. Gel-Clot Tests
      • 10.3.2.3. Rabbit Pyrogen Tests
      • 10.3.2.4. Monocyte Activity Assay
    • 10.3.3. Consumables
    • 10.3.4. Services
      • 10.3.4.1. Endotoxin Testing Services
      • 10.3.4.2. Monocyte Activation Testing Services
  • 10.4. Market Attractiveness Analysis By Products & Services

11. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Source

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Source, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2024-2031
    • 11.3.1. In-vitro based
      • 11.3.1.1. Whole Blood Based Monocytes
      • 11.3.1.2. Peripheral Blood Mononuclear Cells (PBMC) based Monocytes
      • 11.3.1.3. Cell Line Based Monocytes
    • 11.3.2. Animal Based
      • 11.3.2.1. Recombinant factor C (rFC)
      • 11.3.2.2. Bacterial Endotoxin (BET)
      • 11.3.2.3. Rabbit Pyrogen Tests
  • 11.4. Market Attractiveness Analysis By Source

12. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Application

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Source, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
    • 12.3.1. Injectable Therapeutics
    • 12.3.2. Vaccines
    • 12.3.3. Orally Dosed Pharmaceuticals
    • 12.3.4. Biologics
    • 12.3.5. Implantable Medical Devices
    • 12.3.6. Dialysis Liquids
    • 12.3.7. Toxic/immune-modulatory Drugs
    • 12.3.8. Blood-based Product
  • 12.4. Market Attractiveness Analysis By Application

13. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
    • 13.3.1. Pharmaceuticals Companies
    • 13.3.2. Pharmaceuticals Companies
    • 13.3.3. Biotechnology Companies
    • 13.3.4. Medical Device Companies
    • 13.3.5. Diagnostic Laboratories
    • 13.3.6. Clinical Research Organizations(CRO)
    • 13.3.7. Clinical Manufacturing Organizations (CMOs)
  • 13.4. Market Attractiveness Analysis By End User

14. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 14.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2031
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. East Asia
    • 14.3.5. South Asia
    • 14.3.6. Oceania
    • 14.3.7. Middle East and Africa (MEA)
  • 14.4. Market Attractiveness Analysis By Region

15. North America Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. U.S.
      • 15.3.1.2. Canada
    • 15.3.2. By Products & Services
    • 15.3.3. By Source
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis

16. Latin America Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 16.3.1. By Country
      • 16.3.1.1. Brazil
      • 16.3.1.2. Mexico
      • 16.3.1.3. Rest of Latin America
    • 16.3.2. By Products & Services
    • 16.3.3. By Source
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis

17. Europe Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 17.3.1. By Country
      • 17.3.1.1. Germany
      • 17.3.1.2. Italy
      • 17.3.1.3. France
      • 17.3.1.4. U.K.
      • 17.3.1.5. Spain
      • 17.3.1.6. BENELUX
      • 17.3.1.7. Russia
      • 17.3.1.8. Rest of Europe
    • 17.3.2. By Products & Services
    • 17.3.3. By Source
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis

18. South Asia Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Thailand
      • 18.3.1.3. Indonesia
      • 18.3.1.4. Malaysia
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Products & Services
    • 18.3.3. By Source
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis

19. East Asia Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 19.3.1. By Country
      • 19.3.1.1. China
      • 19.3.1.2. Japan
      • 19.3.1.3. South Korea
    • 19.3.2. By Products & Services
    • 19.3.3. By Source
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis

20. Oceania Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 20.3.1. By Country
      • 20.3.1.1. Australia
      • 20.3.1.2. New Zealand
    • 20.3.2. By Products & Services
    • 20.3.3. By Source
    • 20.3.4. By Application
    • 20.3.5. By End User
  • 20.4. Market Attractiveness Analysis
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 21.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Turkey
      • 21.3.1.3. Northern Africa
      • 21.3.1.4. South Africa
      • 21.3.1.5. Rest of Middle East and Africa
    • 21.3.2. By Products & Services
    • 21.3.3. By Source
    • 21.3.4. By Application
    • 21.3.5. By End User
  • 21.4. Market Attractiveness Analysis
  • 21.5. Key Market Participants - Intensity Mapping
  • 21.6. Drivers and Restraints - Impact Analysis

22. Country Wise Pyrogen Testing Market Analysis 2024-2031

  • 22.1. Introduction
    • 22.1.1. Market Value Proportion Analysis, By Key Countries
    • 22.1.2. Global Vs. Country Growth Comparison
  • 22.2. U.S. Pyrogen Testing Market Analysis
    • 22.2.1. By Products & Services
    • 22.2.2. By Source
    • 22.2.3. By Application
    • 22.2.4. By End User
  • 22.3. Canada Pyrogen Testing Market Analysis
    • 22.3.1. By Products & Services
    • 22.3.2. By Source
    • 22.3.3. By Application
    • 22.3.4. By End User
  • 22.4. Mexico Pyrogen Testing Market Analysis
    • 22.4.1. By Products & Services
    • 22.4.2. By Source
    • 22.4.3. By Application
    • 22.4.4. By End User
  • 22.5. Brazil Pyrogen Testing Market Analysis
    • 22.5.1. By Products & Services
    • 22.5.2. By Source
    • 22.5.3. By Application
    • 22.5.4. By End User
  • 22.6. Germany Pyrogen Testing Market Analysis
    • 22.6.1. By Products & Services
    • 22.6.2. By Source
    • 22.6.3. By Application
    • 22.6.4. By End User
  • 22.7. Italy Pyrogen Testing Market Analysis
    • 22.7.1. By Products & Services
    • 22.7.2. By Source
    • 22.7.3. By Application
    • 22.7.4. By End User
  • 22.8. France Pyrogen Testing Market Analysis
    • 22.8.1. By Products & Services
    • 22.8.2. By Source
    • 22.8.3. By Application
    • 22.8.4. By End User
  • 22.9. U.K. Pyrogen Testing Market Analysis
    • 22.9.1. By Products & Services
    • 22.9.2. By Source
    • 22.9.3. By Application
    • 22.9.4. By End User
  • 22.10. Spain Pyrogen Testing Market Analysis
    • 22.10.1. By Products & Services
    • 22.10.2. By Source
    • 22.10.3. By Application
    • 22.10.4. By End User
  • 22.11. Russia Pyrogen Testing Market Analysis
    • 22.11.1. By Products & Services
    • 22.11.2. By Source
    • 22.11.3. By Application
    • 22.11.4. By End User
  • 22.12. BENELUX Pyrogen Testing Market Analysis
    • 22.12.1. By Products & Services
    • 22.12.2. By Source
    • 22.12.3. By Application
    • 22.12.4. By End User
  • 22.13. China Pyrogen Testing Market Analysis
    • 22.13.1. By Products & Services
    • 22.13.2. By Source
    • 22.13.3. By Application
    • 22.13.4. By End User
  • 22.14. Japan Pyrogen Testing Market Analysis
    • 22.14.1. By Products & Services
    • 22.14.2. By Source
    • 22.14.3. By Application
    • 22.14.4. By End User
  • 22.15. South Korea Pyrogen Testing Market Analysis
    • 22.15.1. By Products & Services
    • 22.15.2. By Source
    • 22.15.3. By Application
    • 22.15.4. By End User
  • 22.16. India Pyrogen Testing Market Analysis
    • 22.16.1. By Products & Services
    • 22.16.2. By Source
    • 22.16.3. By Application
    • 22.16.4. By End User
  • 22.17. Thailand Pyrogen Testing Market Analysis
    • 22.17.1. By Products & Services
    • 22.17.2. By Source
    • 22.17.3. By Application
  • 22.18. Australia Pyrogen Testing Market Analysis
    • 22.18.1. By Products & Services
    • 22.18.2. By Source
    • 22.18.3. By Application
    • 22.18.4. By End User
  • 22.19. New Zealand Pyrogen Testing Market Analysis
    • 22.19.1. By Products & Services
    • 22.19.2. By Source
    • 22.19.3. By Application
    • 22.19.4. By End User
  • 22.20. GCC Countries Pyrogen Testing Market Analysis
    • 22.20.1. By Products & Services
    • 22.20.2. By Source
    • 22.20.3. By Application
    • 22.20.4. By End User
  • 22.21. Turkey Pyrogen Testing Market Analysis
    • 22.21.1. By Products & Services
    • 22.21.2. By Source
    • 22.21.3. By Application
    • 22.21.4. By End User
  • 22.22. South Africa Pyrogen Testing Market Analysis
    • 22.22.1. By Products & Services
    • 22.22.2. By Source
    • 22.22.3. By Application
    • 22.22.4. By End User
  • 22.23. Indonesia Pyrogen Testing Market Analysis
    • 22.23.1. By Products & Services
    • 22.23.2. By Source
    • 22.23.3. By Application
    • 22.23.4. By End User
  • 22.24. Malaysia Pyrogen Testing Market Analysis
    • 22.24.1. By Products & Services
    • 22.24.2. By Source
    • 22.24.3. By Application
    • 22.24.4. By End User

23. Market Structure Analysis

  • 23.1. Market Analysis by Tier of Companies
  • 23.2. Market Share Analysis of Top Players
  • 23.3. Market Presence Analysis

24. Competition Analysis

  • 24.1. Competition Dashboard
  • 24.2. Competition Benchmarking
  • 24.3. Competition Deep Dive
    • 24.3.1. Thermo Fisher Scientific
      • 24.3.1.1. Overview
      • 24.3.1.2. Product Portfolio
      • 24.3.1.3. Key Financials
      • 24.3.1.4. SWOT Analysis
      • 24.3.1.5. Strategy Overview
        • 24.3.1.5.1. Marketing Strategy
        • 24.3.1.5.2. Channel Strategy
        • 24.3.1.5.3. Product Strategy
    • 24.3.2. Merck KGaA
      • 24.3.2.1. Overview
      • 24.3.2.2. Product Portfolio
      • 24.3.2.3. Key Financials
      • 24.3.2.4. SWOT Analysis
      • 24.3.2.5. Strategy Overview
        • 24.3.2.5.1. Marketing Strategy
        • 24.3.2.5.2. Channel Strategy
        • 24.3.2.5.3. Product Strategy
    • 24.3.3. Lonza
      • 24.3.3.1. Overview
      • 24.3.3.2. Product Portfolio
      • 24.3.3.3. Key Financials
      • 24.3.3.4. SWOT Analysis
      • 24.3.3.5. Strategy Overview
        • 24.3.3.5.1. Marketing Strategy
        • 24.3.3.5.2. Channel Strategy
        • 24.3.3.5.3. Product Strategy
    • 24.3.4. MAT-BioTech
      • 24.3.4.1. Overview
      • 24.3.4.2. Product Portfolio
      • 24.3.4.3. Key Financials
      • 24.3.4.4. SWOT Analysis
      • 24.3.4.5. Strategy Overview
        • 24.3.4.5.1. Marketing Strategy
        • 24.3.4.5.2. Channel Strategy
        • 24.3.4.5.3. Product Strategy
    • 24.3.5. Promega Corporation
      • 24.3.5.1. Overview
      • 24.3.5.2. Product Portfolio
      • 24.3.5.3. Key Financials
      • 24.3.5.4. SWOT Analysis
      • 24.3.5.5. Strategy Overview
        • 24.3.5.5.1. Marketing Strategy
        • 24.3.5.5.2. Channel Strategy
        • 24.3.5.5.3. Product Strategy
    • 24.3.6. GenScript
      • 24.3.6.1. Overview
      • 24.3.6.2. Product Portfolio
      • 24.3.6.3. Key Financials
      • 24.3.6.4. SWOT Analysis
      • 24.3.6.5. Strategy Overview
        • 24.3.6.5.1. Marketing Strategy
        • 24.3.6.5.2. Channel Strategy
        • 24.3.6.5.3. Product Strategy
    • 24.3.7. Associates of Cape Cod, Inc.
      • 24.3.7.1. Overview
      • 24.3.7.2. Product Portfolio
      • 24.3.7.3. Key Financials
      • 24.3.7.4. SWOT Analysis
      • 24.3.7.5. Strategy Overview
        • 24.3.7.5.1. Marketing Strategy
        • 24.3.7.5.2. Channel Strategy
        • 24.3.7.5.3. Product Strategy
    • 24.3.8. BIOMERIEUX SA
      • 24.3.8.1. Overview
      • 24.3.8.2. Product Portfolio
      • 24.3.8.3. Key Financials
      • 24.3.8.4. SWOT Analysis
      • 24.3.8.5. Strategy Overview
        • 24.3.8.5.1. Marketing Strategy
        • 24.3.8.5.2. Channel Strategy
        • 24.3.8.5.3. Product Strategy
    • 24.3.9. Ella A/S
      • 24.3.9.1. Overview
      • 24.3.9.2. Product Portfolio
      • 24.3.9.3. Key Financials
      • 24.3.9.4. SWOT Analysis
      • 24.3.9.5. Strategy Overview
        • 24.3.9.5.1. Marketing Strategy
        • 24.3.9.5.2. Channel Strategy
        • 24.3.9.5.3. Product Strategy
    • 24.3.10. Hycult Biotech Inc.
      • 24.3.10.1. Overview
      • 24.3.10.2. Product Portfolio
      • 24.3.10.3. Key Financials
      • 24.3.10.4. SWOT Analysis
      • 24.3.10.5. Strategy Overview
        • 24.3.10.5.1. Marketing Strategy
        • 24.3.10.5.2. Channel Strategy
        • 24.3.10.5.3. Product Strategy
    • 24.3.11. Eurofins Biolab Srl
      • 24.3.11.1. Overview
      • 24.3.11.2. Product Portfolio
      • 24.3.11.3. Key Financials
      • 24.3.11.4. SWOT Analysis
      • 24.3.11.5. Strategy Overview
        • 24.3.11.5.1. Marketing Strategy
        • 24.3.11.5.2. Channel Strategy
        • 24.3.11.5.3. Product Strategy
    • 24.3.12. Solvias AG
      • 24.3.12.1. Overview
      • 24.3.12.2. Product Portfolio
      • 24.3.12.3. Key Financials
      • 24.3.12.4. SWOT Analysis
      • 24.3.12.5. Strategy Overview
        • 24.3.12.5.1. Marketing Strategy
        • 24.3.12.5.2. Channel Strategy
        • 24.3.12.5.3. Product Strategy
    • 24.3.13. Wickham Laboratories Ltd.
      • 24.3.13.1. Overview
      • 24.3.13.2. Product Portfolio
      • 24.3.13.3. Key Financials
      • 24.3.13.4. SWOT Analysis
      • 24.3.13.5. Strategy Overview
        • 24.3.13.5.1. Marketing Strategy
        • 24.3.13.5.2. Channel Strategy
        • 24.3.13.5.3. Product Strategy
    • 24.3.14. Sotera Health (Nelson Laboratories, LLC)
      • 24.3.14.1. Overview
      • 24.3.14.2. Product Portfolio
      • 24.3.14.3. Key Financials
      • 24.3.14.4. SWOT Analysis
      • 24.3.14.5. Strategy Overview
        • 24.3.14.5.1. Marketing Strategy
        • 24.3.14.5.2. Channel Strategy
        • 24.3.14.5.3. Product Strategy
    • 24.3.15. Charles River Laboratories
      • 24.3.15.1. Overview
      • 24.3.15.2. Product Portfolio
      • 24.3.15.3. Key Financials
      • 24.3.15.4. SWOT Analysis
      • 24.3.15.5. Strategy Overview
        • 24.3.15.5.1. Marketing Strategy
        • 24.3.15.5.2. Channel Strategy
        • 24.3.15.5.3. Product Strategy
    • 24.3.16. Creative Biolabs
      • 24.3.16.1. Overview
      • 24.3.16.2. Product Portfolio
      • 24.3.16.3. Key Financials
      • 24.3.16.4. SWOT Analysis
      • 24.3.16.5. Strategy Overview
        • 24.3.16.5.1. Marketing Strategy
        • 24.3.16.5.2. Channel Strategy
        • 24.3.16.5.3. Product Strategy
    • 24.3.17. Sanquin Reagents B.V.
      • 24.3.17.1. Overview
      • 24.3.17.2. Product Portfolio
      • 24.3.17.3. Key Financials
      • 24.3.17.4. SWOT Analysis
      • 24.3.17.5. Strategy Overview
        • 24.3.17.5.1. Marketing Strategy
        • 24.3.17.5.2. Channel Strategy
        • 24.3.17.5.3. Product Strategy
    • 24.3.18. Fujifilm Wako Pure Chemical Corporation
      • 24.3.18.1. Overview
      • 24.3.18.2. Product Portfolio
      • 24.3.18.3. Key Financials
      • 24.3.18.4. SWOT Analysis
      • 24.3.18.5. Strategy Overview
        • 24.3.18.5.1. Marketing Strategy
        • 24.3.18.5.2. Channel Strategy
        • 24.3.18.5.3. Product Strategy
    • 24.3.19. MAT Research
      • 24.3.19.1. Overview
      • 24.3.19.2. Product Portfolio
      • 24.3.19.3. Key Financials
      • 24.3.19.4. SWOT Analysis
      • 24.3.19.5. Strategy Overview
        • 24.3.19.5.1. Marketing Strategy
        • 24.3.19.5.2. Channel Strategy
        • 24.3.19.5.3. Product Strategy
    • 24.3.20. Xiamen Bioendo Technology Co. Ltd.
      • 24.3.20.1. Overview
      • 24.3.20.2. Product Portfolio
      • 24.3.20.3. Key Financials
      • 24.3.20.4. SWOT Analysis
      • 24.3.20.5. Strategy Overview
        • 24.3.20.5.1. Marketing Strategy
        • 24.3.20.5.2. Channel Strategy
        • 24.3.20.5.3. Product Strategy
    • 24.3.21. Microcoat Biotechnologie GmbH
      • 24.3.21.1. Overview
      • 24.3.21.2. Product Portfolio
      • 24.3.21.3. Key Financials
      • 24.3.21.4. SWOT Analysis
      • 24.3.21.5. Strategy Overview
        • 24.3.21.5.1. Marketing Strategy
        • 24.3.21.5.2. Channel Strategy
        • 24.3.21.5.3. Product Strategy
    • 24.3.22. PerkinElmer Inc.
      • 24.3.22.1. Overview
      • 24.3.22.2. Product Portfolio
      • 24.3.22.3. Key Financials
      • 24.3.22.4. SWOT Analysis
      • 24.3.22.5. Strategy Overview
        • 24.3.22.5.1. Marketing Strategy
        • 24.3.22.5.2. Channel Strategy
        • 24.3.22.5.3. Product Strategy
    • 24.3.23. Orchid Scientific & Innovative Pvt Ltd.
      • 24.3.23.1. Overview
      • 24.3.23.2. Product Portfolio
      • 24.3.23.3. Key Financials
      • 24.3.23.4. SWOT Analysis
      • 24.3.23.5. Strategy Overview
        • 24.3.23.5.1. Marketing Strategy
        • 24.3.23.5.2. Channel Strategy
        • 24.3.23.5.3. Product Strategy

25. Assumptions and Acronyms Used

26. Research Methodology